CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
Leukapheresis +1 moreprocedure
Likely dose
Autologous stem cell infusion via image-guided injection; specific dose not statedAI-extracted
Key inclusion· 6
  • ✓Age 20 to 65 years
  • ✓Chronic liver failure with abnormal albumin, bilirubin, and/or prothrombin time
  • ✓Unsuitable for liver transplantation
  • ✓WHO performance status <2
Key exclusion· 7
  • ✕Age <20 or >65 years
  • ✕Pregnancy or lactation
  • ✕Recent recurrent gastrointestinal bleeding
  • ✕Spontaneous bacterial peritonitis

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00147043
NCT00147043N/ACompleted
CompareCT.gov

Adult Stem Therapy for Patients With Liver Insufficiency

Imperial College London·interventional·Posted Sep 7, 2005·Updated Oct 3, 2019

In Brief

A clinical study evaluating Leukapheresis and Infusion of stem cells via image guided scan for Liver Cirrhosis. Completed, enrolled 5 participants across 1 site.

Detailed Summary

In order to determine the clinical application potential of adult stem cells we propose to investigate the safety and toxicity of infusing adult stem cells in the hepatic artery or portal vein of five patients with chronic liver insufficiency and to identify any clinical benefit if such occurs. Objectives: 1. To assess safety and treatment related toxicities 2. To determine clinical benefit or deterioration by monitoring changes in liver function

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Cirrhosis
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 7, 2005
Enrollment StartJan 1, 2005
Primary CompletionJun 1, 2005
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 20.8 years ago

Interventions

Leukapheresisprocedure

Infusion of stem cells via image guided scanprocedure